Adjustable Continence Therapy (ACT®) balloons to treat female stress urinary incontinence: effectiveness, safety and risk factors of failure and complication.
Compression device
Intrinsic sphincter deficiency
Urinary incontinence
Women
Journal
International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
03
04
2022
accepted:
01
06
2022
medline:
28
3
2023
pubmed:
26
6
2022
entrez:
25
6
2022
Statut:
ppublish
Résumé
To assess the effectiveness, safety and risk factors of failure and complications associated with Adjustable Continence Therapy (ACT®) balloons as a treatment for female stress urinary incontinence (SUI). In the present multicentric retrospective study, all women implanted with ACT® balloons between 2000 and 2018 were considered eligible. Effectiveness and safety were assessed at 1 year, and risk factors for failure and complications were sought. The effectiveness was categorized into three distinct groups: Success = maximum 1 pad/day and patient's impression of improvement using a numerical rating scale (NRS) ≥ 8/10; Improvement = decrease of daily pad use and NRS ≥ 5/10; Failure = increase or stability of daily pad use or NRS < 5/10. The intra- and postoperative surgical complications were collected. Over the study period, 281 women were included. Among them, 104 (37.0%), 94 (33.5%) and 83 (29.5%) were categorized as success, improvement, and failure, respectively. Intra-, early and late postoperative complications occurred in 13 (4.6%), 35 (12.5%) and 75 (26.7%) women, respectively. Most early surgical complications were minor according to the Dindo-Clavien classification. Of women that presented a late postoperative surgical complication, 64 (22.8%) underwent an explantation performed under local or general anesthesia without associated sequalae. The short-term effectiveness associated with ACT® balloons, their minimally invasive implantation and the frequent but easily manageable and sequelae-free complications suggest that they should be part of the therapeutic arsenal for female SUI.
Identifiants
pubmed: 35751672
doi: 10.1007/s00192-022-05275-6
pii: 10.1007/s00192-022-05275-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
877-883Informations de copyright
© 2022. The International Urogynecological Association.
Références
Sussman RD, Syan R, Brucker BM. Guideline of guidelines: urinary incontinence in women. BJU Int. 2019. https://doi.org/10.1111/bju.14927 .
Lucas MG, Bosch RJL, Burkhard FC, et al. EAU guidelines on surgical treatment of urinary incontinence. Eur Urol. 2012;62:1118–29. https://doi.org/10.1016/j.eururo.2012.09.023 .
doi: 10.1016/j.eururo.2012.09.023
pubmed: 23040204
Chartier-kastler E, Costa P, Ben Naoum K, et al. Etude Française prospective multicentrique de l’utilisation des ballons ACT® pour le traitement de l’incontinence urinaire d’effort chez la femme. Progrès en Urologie. 2007;17:1372–7. https://doi.org/10.1016/S1166-7087(07)78580-9 .
doi: 10.1016/S1166-7087(07)78580-9
pubmed: 18271425
Kocjancic E, Crivellaro S, Smith JJ III, et al. Adjustable Continence Therapy for treatment of recurrent female urinary incontinence. J Endourol. 2008;22:1403–8. https://doi.org/10.1089/end.2008.0027 .
doi: 10.1089/end.2008.0027
pubmed: 18613782
Wachter J, Henning A, Roehlich M, et al. Adjustable continence therapy for female urinary incontinence: a minimally invasive option for difficult cases. Urol Int. 2008;81:160–6. https://doi.org/10.1159/000144054 .
doi: 10.1159/000144054
pubmed: 18758213
Aboseif SR, Franke EI, Nash SD, et al. The adjustable continence therapy system for recurrent female stress urinary incontinence: 1-year results of the North America Clinical Study Group. J Urol. 2009;181:2187–91. https://doi.org/10.1016/j.juro.2009.01.039 .
doi: 10.1016/j.juro.2009.01.039
pubmed: 19296967
Kocjancic E, Crivellaro S, Ranzoni S, et al. Adjustable continence therapy for severe intrinsic sphincter deficiency and recurrent female stress urinary incontinence: long-term experience. J Urol. 2010;184:1017–21. https://doi.org/10.1016/j.juro.2010.05.024 .
doi: 10.1016/j.juro.2010.05.024
pubmed: 20643464
Vayleux B, Luyckx F, Thélu S, et al. Adjustable Continence Therapy in women, middle term follow-up and a new technique for balloon positioning. Prog Urol. 2010;20:520–6. https://doi.org/10.1016/j.purol.2010.01.010 .
doi: 10.1016/j.purol.2010.01.010
pubmed: 20656275
Aboseif SR, Sassani P, Franke EI, et al. Treatment Of Moderate to severe female stress urinary incontinence with the adjustable continence therapy (ACT) device after failed surgical repair. World J Urol. 2011;29:249–53. https://doi.org/10.1007/s00345-010-0589-4 .
doi: 10.1007/s00345-010-0589-4
pubmed: 20959993
Biyani CS, Pecanka J, Rouprêt M, et al. Intraoperative Adverse Incident Classification (EAUiaiC) by the European Association of Urology ad hoc Complications Guidelines Panel. Eur Urol. 2020;77:601–10. https://doi.org/10.1016/j.eururo.2019.11.015 .
doi: 10.1016/j.eururo.2019.11.015
pubmed: 31787430
Dindo D, Demartines N, Clavien P-A. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Annals Surg. 2004;240:205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae .
doi: 10.1097/01.sla.0000133083.54934.ae
Phé V, Nguyen K, Rouprêt M, et al. A systematic review of the treatment for female stress urinary incontinence by ACT® balloon placement (Uromedica, Irvine, CA, USA). World J Urol. 2014;32:495–505. https://doi.org/10.1007/s00345-013-1117-0 .
doi: 10.1007/s00345-013-1117-0
pubmed: 23783882
Gregori A, Romanò AL, Scieri F, et al. Transrectal ultrasound-guided implantation of Adjustable Continence Therapy (ProACT): surgical technique and clinical results after a mean follow-up of 2 years. Eur Urol. 2010;57:430–6. https://doi.org/10.1016/j.eururo.2009.11.031 .
doi: 10.1016/j.eururo.2009.11.031
pubmed: 19942340
Rouprêt M, Misraï V, Gosseine P-N, et al. Management Of Stress urinary incontinence following prostate surgery with minimally invasive adjustable continence balloon implants: functional results from a single center prospective study. J Urol. 2011;186:198–203. https://doi.org/10.1016/j.juro.2011.03.016 .
doi: 10.1016/j.juro.2011.03.016
pubmed: 21575974
Vayleux B, Rigaud J, Luyckx F, et al. Female urinary incontinence and artificial urinary sphincter: study of efficacy and risk factors for failure and complications. Eur Urol. 2011;59:1048–53. https://doi.org/10.1016/j.eururo.2011.03.006 .
doi: 10.1016/j.eururo.2011.03.006
pubmed: 21420781